The world of cancer treatment is rapidly advancing. Scientists are discovering new ways to target cancers, making drugs more effective and more precise. But with these new advancements, comes a long process of approvals involving many steps to allow Canadians to access them. Not only do new drugs need to be approved for safety and efficacy by regulatory bodies like Health Canada and the Canadian Drug Agency, but then they also need to go through price negotiations between the drug manufacturers and the provinces . These negotiations set the cost that every province will pay to the drug company once the drug is added to public drug plans.